Crea il mio profilo
Accesso pubblico
Visualizza tutto13 articoli
2 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Jean-Charles SoriaAmgen R&DEmail verificata su amgen.com
- christophe massardUniversité Paris-Saclay, Faculté de Médecine, Drug Development Department (DITEP), Gustave RoussyEmail verificata su gustaveroussy.fr
- Antoine HollebecqueConsultant, Gustave Roussy Cancer Campus, VillejuifEmail verificata su gustaveroussy.fr
- Roger SUNRadiation Oncology & Radiomics team, INSERM U1030, Gustave Roussy Cancer Center, ParisEmail verificata su gustaveroussy.fr
- Stephane ChampiatGustave RoussyEmail verificata su igr.fr
- Elaine LimkinGustave RoussyEmail verificata su gustaveroussy.fr
- Charlotte RobertGustave Roussy, VillejuifEmail verificata su gustaveroussy.fr
- Sylvain ReuzéGE HealthCareEmail verificata su ge.com
- Antoine SchernbergGustave RoussyEmail verificata su gustaveroussy.fr
- loriot yGustave RoussyEmail verificata su gustaveroussy.fr
- Serge KoscielnyGustave RoussyEmail verificata su gustaveroussy.fr
- Michel DucreuxUniversité Paris-Saclay, Gustave RoussyEmail verificata su gustaveroussy.fr
- Chargari CyrusProfessor of Radiation Oncology, Pitié Salpêtrière University HospitalEmail verificata su aphp.fr
- Stefan MichielsOffice Biostatistics & Epidemiology, Gustave Roussy; Oncostat, Univ. Paris Saclay, INSERMEmail verificata su gustaveroussy.fr
- Frederic CommoGustave RoussyEmail verificata su gustaveroussy.fr
- François BidaultRadiology department _ BIOMAPSEmail verificata su gustaveroussy.fr
- Antonin LevyGustave Roussy & Université Paris SaclayEmail verificata su gustaveroussy.fr
- Evangelia I. ZacharakiComKardia Inc.Email verificata su comkardia.com
- Sandrine AspeslaghEarly drug development dept, CTCUEmail verificata su bordet.be
- Pierre Blanchard, MD PhDGustave RoussyEmail verificata su gustaveroussy.fr
Segui
Charles Ferté
Resilience - ex: Daiichi Sankyo, Relay Tx, AstraZeneca, Institut Gustave Roussy
Email verificata su resilience.care